β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction

By sjmartinez • May 22, 2024

LaFon DC, Helgeson ES, Lindberg S, Voelker H, Bhatt SP, Casaburi R, Cassady SJ, Connett J, Criner GJ, Hatipoglu U, Kaminsky DA, Kunisaki KM, Lazarus SC, McEvoy CE, Reed RM, Sciurba FC, Stringer W, Dransfield MT. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction. JAMA Netw Open. 2024 May 1;7(5):e247535. doi: 10.1001/jamanetworkopen.2024.7535. PMID: 38771577.

Tags: Harbor UCLA, Publications, Pulmonary, Critical Care & Sleep Medicine

β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, Alkhazraji S, Uppuluri P, Ostroff G, Ibrahim AS. β-Glucan chitosan particle provides[...]

Muscle Matters: Poor Muscle Quality Increases Mortality Risk in Early CKD

Hamdan H, Roshanravan B, Kalantar-Zadeh K. Muscle Matters: Poor Muscle Quality Increases Mortality Risk in Early CKD. Clin J Am Soc Nephrol. 2026 May 15.[...]

Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis

Zhang Y, Winter A, Ficociello LH, Arya S, Stuard S, Usvyat LA, Kalantar-Zadeh K. Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International[...]